Notícias Eulerpool Nektar Therapeutics

Nektar Therapeutics Eulerpool-AFX

Nektar Therapeutics Notícias de ações

Nektar Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Nektar Therapeutics nós reunimos aqui.

• 1 de novembro ·

  GuruFocus
  Nektar Therapeutics (NKTR) Stock Surges Amidst Mixed Financials
• 31 de outubro ·

  Yahoo
  Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets
• 29 de outubro ·

  Yahoo
  Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases
• 29 de outubro ·

  TipRanks
  Nektar’s rezpegaldesleukin Phase 1 study featured in peer-reviewed publication
• 29 de outubro ·

  Thefly.com
  Nektar's rezpegaldesleukin Phase 1 study featured in peer-reviewed publication
• 28 de outubro ·

  GuruFocus
  Nektar Therapeutics (NKTR) Shares Surge Amidst Moderate Biotech Sector Gains
• 17 de outubro ·

  Yahoo
  Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
• 17 de outubro ·

  Thefly.com
  Nektar says published Phase 1 NKTR-25 data show favorable efficacy
• 17 de outubro ·

  Seeking Alpha
  Nektar sees promising phase 1 results of NKTR-255 in B-cell lymphoblastic leukemia
• 4 de outubro ·

  GuruFocus
  Nektar Therapeutics (NKTR) Stock Surges Amid Market Fluctuations